| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Pozetaldogene ormesparvovec | SBT-101 | Phase 2 Clinical | SwanBio Therapeutics Ltd | Adrenoleukodystrophy | Details |
| TYF-ABCD1 | TYF-ABCD1 | Clinical | Shenzhen Geno-Immune Medical Institute | Adrenoleukodystrophy | Details |
| English Name | Research Code | Highest Development Stage | Company | Earliest Brand Name | Earliest Approval Country | Earliest Indication | Earliest Approval Company | Earliest Approval Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Elivaldogene autotemcel | Approved | Genetix Biotherapeutics Inc, Inserm | Lenti-D, Skysona | United States | Adrenoleukodystrophy | Genetix Biotherapeutics Inc | 2021-07-27 | Adrenoleukodystrophy | Details |